Healthcare industry
Research Topic
Language: English
This is a research topic created to provide authors with a place to attach new problem publications.
Research topics above this in the hierarchy
Research problems linked to this topic
- Detailed data on uptake and access of medicines and medical technologies at the level of each commissioning unit.
- Detailed data on companies that specialise in the provision of AI services in life sciences.
- Detailed company data on sales to the NHS.
- Estimates of the potential market size for AI-related services in the life sciences sector.
- The role that all parts of the health system, from community and primary care through to hospital-based and social care, play in delivering better outcomes for people, and how the system can work effectively together to plan for and respond to compound pressures including infections with pandemic potential.
- Evidence on inequality of access to and benefit from treatments.
- What are the most effective ways to engage employers, health professionals, employees and other relevant stakeholders to retain and support disabled people and people with health conditions in employment? What policies and processes do employers have in place that could influence employee health, well-being and productivity (such as sick pay, access to occupational health services, health insurance provision)?
- Manufacturing Innovation: We would like to have a more comprehensive forward look for new drugs, devices, or other therapeutics to identify potential innovations faster.
- What impact will the copper switch off have on the resilience for networks and their usage? How might it impact public sector service providers, such as care homes, emergency services and other NHS sites? How aware are customers that the copper switch off is taking place and what risks come from this for the market?
- Estimates of the benefit and impact of introducing new technologies and therapeutics to the NHS.
- A Scoping Review Protocol to Identify Strategies to Recruit Underserved Populations to Clinical Trials
- Detailed data on the price per QALY associated with each medicine and medical technology purchased by the NHS.
- We would like to understand how clinical trial activity is affected by the broader commercial environment and, in particular, price regulation and other cost control measures.
- Estimates of the returns to R&D spending in these disease areas.
- Detailed data on the dates of regulatory approval and cost-effectiveness appraisal of medicines and medical technologies.